175 related articles for article (PubMed ID: 20214756)
1. Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.
Khan MH; Okumura J; Sovannarith T; Nivanna N; Akazawa M; Kimura K
Trop Med Int Health; 2010 May; 15(5):639-44. PubMed ID: 20214756
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010.
Yoshida N; Khan MH; Tabata H; Dararath E; Sovannarith T; Kiet HB; Nivanna N; Akazawa M; Tsuboi H; Tanimoto T; Kimura K
BMC Pharmacol Toxicol; 2014 Mar; 15():13. PubMed ID: 24593851
[TBL] [Abstract][Full Text] [Related]
3. Counterfeit and substandard antimalarial drugs in Cambodia.
Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
[TBL] [Abstract][Full Text] [Related]
4. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
[TBL] [Abstract][Full Text] [Related]
5. [Are there counterfeit medicines in Croatia?].
Tomić S; Milcić N; Sokolić M; Sucić AF; Martinac AI
Lijec Vjesn; 2010; 132(3-4):81-6. PubMed ID: 20540433
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011-2013.
Rahman MS; Yoshida N; Tsuboi H; Sokchamroeun U; Keila T; Sovannarith T; Kiet HB; Dararath E; Akimoto Y; Tanimoto T; Kimura K
Am J Trop Med Hyg; 2019 Nov; 101(5):1018-1026. PubMed ID: 31516106
[TBL] [Abstract][Full Text] [Related]
7. [Quality of medicines in least developed countries].
Videau JY
Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
[TBL] [Abstract][Full Text] [Related]
8. Substandard and counterfeit medicines.
Rassool GH
J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
[No Abstract] [Full Text] [Related]
9. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
Vijaykadga S; Cholpol S; Sitthimongkol S; Pawaphutanan A; Pinyoratanachot A; Rojanawatsirivet C; Kovithvattanapong R; Thimasarn K
Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():5-10. PubMed ID: 17547041
[TBL] [Abstract][Full Text] [Related]
10. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
Tadeg H; Berhane Y
East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
[TBL] [Abstract][Full Text] [Related]
11. [Counterfeit medicines: a growing threat].
Barbereau S
Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
[TBL] [Abstract][Full Text] [Related]
12. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
[TBL] [Abstract][Full Text] [Related]
13. Spurious and counterfeit drugs: a growing industry in the developing world.
Gautam CS; Utreja A; Singal GL
Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
[TBL] [Abstract][Full Text] [Related]
15. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
Chauvé M
C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines.
Gaudiano MC; Antoniella E; Bertocchi P; Valvo L
J Pharm Biomed Anal; 2006 Sep; 42(1):132-5. PubMed ID: 16517111
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of public awareness campaigns on counterfeit medicines in Cotonou, Benin].
Abdoulaye I; Chastanier H; Azondekon A; Dansou A; Bruneton C
Med Trop (Mars); 2006 Dec; 66(6):615-8. PubMed ID: 17286035
[TBL] [Abstract][Full Text] [Related]
18. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
19. An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation.
Gaudiano MC; Di Maggio A; Antoniella E; Valvo L; Bertocchi P; Manna L; Bartolomei M; Alimonti S; Rodomonte AL
J Pharm Biomed Anal; 2008 Sep; 48(2):303-9. PubMed ID: 18243626
[TBL] [Abstract][Full Text] [Related]
20. Counterfeit drugs: implications for health.
ten Ham M
Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
